20352 Federal Register / Vol. 72, No. 78 / Tuesday April 24, 2007 / Notices 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nigms.nih.gov/about/ 

advisory_council.html, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: April 18, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2033 Filed 4–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; Novel Mechanisms of 

Behavior Change in Alcoholism Treatment. 

Date: April 27, 2007. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Katrina L. Foster, PhD, 

Scientific Review Administrator, National 

Institute on Alcohol Abuse and Alcoholism, 

National Institutes of Health, 5635 Fishers 

Lane, Rm. 3037, Rockville, MD 20852, 301–

443–3037, katrina@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS) 

Dated: April 17, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2037 Filed 4–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Cellular and Inflammatory 

Anaphylaxis Pathways. 

Date: May 22, 2007. 

Time: 11:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Room 3118, Bethesda, MD 20817, (Telephone 

Conference Call). 

Contact Person: Sujata Vijh, PhD, Scientific 

Review Administrator, Scientific Review 

Program, Division of Extramural Activities, 

NIAID/NIH/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892, 301–594–

0985, vijhs@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: April 18, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2039 Filed 4–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Digestive Sciences 

Integrated Review Group; Gastrointestinal 

Mucosal Pathobiology Study Section. 

Date: June 4, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Georgetown Suites, 1111 30th Street, 

NW., Washington, DC 20007. 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435–

0682, perrinp@csr.nih.gov. 

Name of Committee: Oncological Sciences 

Integrated Review Group; Molecular 

Oncogenesis Study Section. 

Date: June 4–5, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Joanna M. Watson, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 78 / Tuesday April 24, 2007 / Notices 20353 

Health, 6701 Rockledge Drive, Room 6208, 

MSC 7804, Bethesda, MD 20892, 301–435–

1048. watsonjo@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group, Biodata Management and Analysis 

Study Section. 

Date: June 4, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Marc Rigas, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4194, MSC 7826, 

Bethesda, MD 20892, 301–402–1074, 

rigasm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Pilot and 

Feasibility Studies and Digestive Diseases 

and Nutrition (R21). 

Date: June 5, 2007. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Georgetown Suites, 1111 30th Street, 

NW., Washington, DC 20007. 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435–

0682, perrinp@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Motor Function, Speech and 

Rehabilitation Study Section. 

Date: June 11, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Washington, 15th Street and 

Pennsylvania Avenue, NW., Washington, DC 

20004. 

Contact Person: Biao Tian, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 3089B, MSC 7848, 

Bethesda, MD 20892, (301) 402–4411, 

tianbi@csr.nih.gov. 

Name of Committee: Oncological Sciences 

Integrated Review Group; Cancer Biomarkers 

Study Section. 

Date: June 12–13, 2007. 

Time: 7:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Hilton, 620 Perry 

Parkway, Gaithersburg, MD 20877. 

Contact Person: Mary Bell, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 6188, MSC 7804, 

Bethesda, MD 20892, (301) 451–8754, 

bellmar@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Host Interactions with Bacterial Pathogens 

Study Section. 

Date: June 13, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Marian Wachtel, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3208, 

MSC 7858, Bethesda, MD 20892, 301 435–

1148, wachtelm@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group; Biomedical 

Computing and Health Informatics Study 

Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Bill Bunnag, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5124, 

MSC 7854, Bethesda, MD 20892, (301) 435–

1177, bunnagb@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group; Nursing 

Science: Children and Families Study 

Section. 

Date: June 14, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Melinda Tinkle, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3141, 

MSC 7770, Bethesda, MD 20892, (301) 594–

6594, tinklem@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Virology. 

Date: June 14, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia venue, 

NW., Washington, DC 20037. 

Contact Person: Robert Freund, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, 301–435–

1050, freundr@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group; Cellular and 

Molecular Immunology—A Study Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal City Marriott, 1999 Jefferson 

Davis Highway, Arlington, VA 22202. 

Contact Person: Samuel C. Edwards, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4200, 

MSC 7812, Bethesda, MD 20892, 301–435–

1152, edwardss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Macromolecular Structure and Function 

Study Section D ‘‘Computational 

Biophysics’’. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: James W. Mack, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4154, 

MSC 7806, Bethesda, MD 20892, 301–435–

2037, mackj2@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group; Nursing 

Science: Adults and Older Adults Study 

Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn, Tysons Corner, 1960 

Chain Bridge Road, McLean, VA 22102. 

Contact Person: Gertrude K. McFarland, 

DNSC, FAAN, Scientific Review 

Administrator, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3156, MSC 7770, Bethesda, MD 

20892, 301–435–1784, mcfarlag@csr.nih.gov. 

Name of Committee: Hematology 

Integrated Review Group; Erythrocyte and 

Leukocyte Biology Study Section. 

Date: June 14, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Delia Tang, MD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4126, MSC 7802, 

Bethesda, MD 20892, 301–435–2506, 

tangd@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Biology and 

Diseases of the Posterior Eye Study Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Michael H. Chaitin, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7850, Bethesda, MD 20892, (301) 435–

0910, chaitinm@csr.nih.gov. 

Name of Committee: Cardiovascular 

Sciences Integrated Review Group; 

Hypertension and Microcirculation Study 

Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza Hotel, 10 Thomas 

Circle, NW., Washington, DC 20005. 

Contact Person: Al-Ping Zou, PhD, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–435–

1777, zouai@csr.nih.gov. 


jlentini on PROD1PC65 with NOTICES
20354 Federal Register / Vol. 72, No. 78 / Tuesday April 24, 2007 / Notices 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurotoxicology 

and Alcohol Study Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Joseph G. Rudolph, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–435–

2212, josephru@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group; 

Epidemiology of Cancer Study Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Admiral Fell Inn, 888 South 

Broadway, Baltimore, MD 21231. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, (301) 435–

0684, wieschd@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group; Immunity and Host 

Defense Study Section. 

Date: June 14–15, 2007. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza Hotel, 10 Thomas 

Circle, NW., Washington, DC 20005. 

Contact Person: Patrick K. Lai, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435–

1052, laip@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neurogenesis and Cell Fate 

Study Section. 

Date: June 14–15, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1257, baizerl@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Synthetic and Biological 

Chemistry B Study Section. 

Date: June 14–15, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Hotel, 8120 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mike Radtke, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4176, 

MSC 7806, Bethesda, MD 20892, 301–435–

1728, radtkem@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 17, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2035 Filed 4–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Opioid Drugs in Maintenance and 

Detoxification Treatment of Opiate 

Addiction; Public Notice of Revocation 

of Certification 

AGENCY: Substance Abuse and Mental 

Health Services Administration 

(SAMHSA), Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

has revoked the certification to provide 

opioid assisted treatment for the three 

opioid treatment programs listed below. 

DATES: The revocation of certification 

was effective on March 20, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Nicholas Reuter, Center for Substance 

Abuse Treatment (CSAT), Division of 

Pharmacologic Therapies, SAMHSA, 

One Choke Cherry Road, Rm 2–1063, 

Rockville, MD 20857, (240) 276–2716, email: Nicholas.Reuter@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In a notice published in the Federal 

Register of January 17, 2001 (66 FR 

4076, January 17, 2001), the Substance 

Abuse and Mental health Services 

Administration (SAMHSA) issued final 

regulations for the use of narcotic drugs 

in maintenance and detoxification 

treatment of opioid addiction. That final 

rule established an accreditation-based 

regulatory system under 42 CFR part 8 

(‘‘Certification of Opioid Treatment 

Programs,’’ ‘‘OTPs’’). The SAMHSA 

regulations establish the standards for 

determining that practitioners 

(programs) are qualified for Drug 

Enforcement Administration (DEA) 

registration under 21 U.S.C. 821(g)(1). 

Qualified programs are granted 

certification. 

The regulations establish the 

conditions for certification as well as 

the criteria for the suspension or 

revocation of SAMHSA certification. In 

addition, Subpart C sets forth the 

procedures for review of suspension or 

proposed revocation of OTP 

certification. 

The Administrator of SAMHSA 

proposed to decertify these three 

programs in August 2006. As set forth 

under 42 CFR part 8, subpart C, each 

OTP requested a review of the 

Administrator’s proposal, and submitted 

documents and briefs to a designated 

reviewing official for consideration, that 

were incorporated into an 

administrative review record. After 

considering the available information 

and evidence, the reviewing officials, in 

upholding the Administrator’s proposal 

to revoke certification, found that the 

OTPs listed below were in violation of 

Federal Opioid Treatment Program 

Regulations (42 CFR § 8.11,8.14). 

1. New Horizon Rehabilitation 

Services, 4809 W. Chicago Ave., 

Chicago, IL 60651. 

2. Turning Point Treatment Center, 

Inc., 210 Commerce St., Blairsville, 

Georgia 30512. 

3. Bay Area C.A.R.E. Center, Inc., 

3138 South Alameda, Corpus Christi, 

Texas 78404. 

Dated: April 13, 2007. 

Terry L. Cline, 

Administrator, Substance Abuse and Mental 

Health Services Administration. 

[FR Doc. 07–1994 Filed 4–23–07; 8:45 am] 

BILLING CODE 4160–20–M 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5117–N–34] 

Notice of Submission of Proposed 

Information Collection to OMB; 

Servicemembers Civil Relief 

AGENCY: Office of the Chief Information 

Officer, HUD. 

ACTION: Notice. 

SUMMARY: The proposed information 

collection requirement described below 

has been submitted to the Office of 

Management and Budget (OMB) for 

review, as required by the Paperwork 

Reduction Act. The Department is 

soliciting public comments on the 

subject proposal. 

Federal law requires lenders to send 

a statement or notice to homeowners in 

default explaining the mortgage and 

foreclosure rights of servicemembers 

and their dependents under the 

Servicemembers Civil Relief Act (50 


jlentini on PROD1PC65 with NOTICES